Eidam; Hilary Schenck
Patent Applications and Registrations
Patent applications and USPTO patent grants for Eidam; Hilary Schenck.The latest application filed is for "ghrelin o-acyltransferase inhibitors".
- Eidam; Hilary Schenck - Stevenage GB
- Eidam; Hilary Schenck - Collegeville PA
- Eidam; Hilary Schenck - King of Prussia PA
| Patent | Date |
|---|---|
| Ghrelin O-acyltransferase Inhibitors App 20220213076 - Bandyopadhyay; Anish ; et al. | 2022-07-07 |
| Ghrelin O-acyltransferase inhibitors Grant 11,312,709 - Bandyopadhyay , et al. April 26, 2 | 2022-04-26 |
| Ghrelin O-acyltransferase Inhibitors App 20210053955 - Bandyopadhyay; Anish ; et al. | 2021-02-25 |
| Chemical compounds Grant 10,851,053 - Axten , et al. December 1, 2 | 2020-12-01 |
| Chemical Compounds App 20200297710 - AXTEN; Jeffrey Michael ; et al. | 2020-09-24 |
| Hydroxy Formamide Derivatives And Their Use App 20200095217 - DOWDELL; Sarah E. ; et al. | 2020-03-26 |
| Hydroxy formamide derivatives and their use Grant 10,450,288 - Dowdell , et al. Oc | 2019-10-22 |
| Chemical Compounds App 20190298705 - AXTEN; Jeffrey Michael ; et al. | 2019-10-03 |
| Compounds as rearranged during transfection (RET) inhibitors Grant 10,294,236 - Cheung , et al. | 2019-05-21 |
| Chemical Compounds App 20190144384 - AXTEN; Jeffrey Michael ; et al. | 2019-05-16 |
| Novel Compounds As Rearranged During Transfection (ret) Inhibitors App 20180099976 - Cheung; Mui ; et al. | 2018-04-12 |
| Compounds as rearranged during transfection (RET) inhibitors Grant 9,879,021 - Cheung , et al. January 30, 2 | 2018-01-30 |
| Novel Compounds As Rearranged During Transfection (ret) Inhibitors App 20170298074 - CHEUNG; Mui ; et al. | 2017-10-19 |
| Compounds as rearranged during transfection (RET) inhibitors Grant 9,789,100 - Eidam October 17, 2 | 2017-10-17 |
| Crystalline Forms Of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-n-(5-(1,1,1- -trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide App 20170283404 - CHEUNG; Mui ; et al. | 2017-10-05 |
| Hydroxy Formamide Derivatives And Their Use App 20160340328 - DOWDELL; Sarah E. ; et al. | 2016-11-24 |
| TRPV4 antagonists Grant 9,487,507 - Brooks , et al. November 8, 2 | 2016-11-08 |
| Novel Compounds As Rearranged During Transfection (ret) Inhibitors App 20160271123 - EIDAM; Hilary Schenck | 2016-09-22 |
| Pyridine derivatives as rearranged during transfection (RET) kinase inhibitors Grant 9,382,238 - Eidam July 5, 2 | 2016-07-05 |
| Pyridine Derivatives As Rearranged During Transfection (ret) Kinase Inhibitors App 20160002215 - EIDAM; Hilary Schenck | 2016-01-07 |
| TRPV4 antagonists Grant 9,187,464 - Brooks , et al. November 17, 2 | 2015-11-17 |
| Compounds as rearranged during transfection (RET) inhibitors Grant 9,035,063 - Eidam , et al. May 19, 2 | 2015-05-19 |
| Compounds As Rearranged During Transfection (ret) Inhibitors App 20150099762 - EIDAM; Hilary Schenck ; et al. | 2015-04-09 |
| Compounds as rearranged during transfection (RET) inhibitors Grant 8,937,071 - Eidam , et al. January 20, 2 | 2015-01-20 |
| Novel Compounds As Rearranged During Transfection (ret) Inhibitors App 20140275111 - EIDAM; Hilary Schenck ; et al. | 2014-09-18 |
| Trpv4 Antagonists App 20140121206 - Brooks; Carl ; et al. | 2014-05-01 |
| Trpv4 Antagonists App 20140113916 - Brooks; Carl ; et al. | 2014-04-24 |
| TRPV4 antagonists Grant 8,450,484 - Bury , et al. May 28, 2 | 2013-05-28 |
| Spiroindolines as modulators of chemokine receptors Grant 8,431,590 - Budzik , et al. April 30, 2 | 2013-04-30 |
| Trpv4 Antagonists App 20110130400 - Bury; Michael Jonathan ; et al. | 2011-06-02 |
| Spiroindolines As Modulators Of Chemokine Receptors App 20110034499 - Budzik; Brian W. ; et al. | 2011-02-10 |
| Spiroindolines as modulators of chemokine receptors Grant 7,723,350 - Eidam , et al. May 25, 2 | 2010-05-25 |
| Spiroindolines As Modulators Of Chemokine Receptors App 20080318990 - Eidam; Hilary Schenck ; et al. | 2008-12-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 